You have successfully logged out.

Hello !
Logout

Your Way to Confidence

SeQuent® Coronary Drug Coated Balloons​

Enter the world of SeQuent® DCB treatment with cutting-edge balloon technology and a proven​ leader at your side – for more drug options, more clinical data, high-quality support and the​ confidence you’re aiming for.

Interventional cardiologists working in the catheter lab​

Want to accelerate your DCB learning curve?


B. Braun offers an extensive educational program designed to enhance your expertise.

Contact us
Coronary Paclitaxel Coated Balloon and Sirolimus Coated Balloon
Paclitaxel coated balloon SeQuent® Please NEO

SeQuent® Please NEO

Best Investigated DCB

  • > 0

    published studies

  • > 0

    documented patients

  • > 0

    countries

Publications for SeQuent® Please / NEO

The coronary DCB has been investigated in more than 110 studies with over 25,000 documented patients, conducted in more than 20 countries.
Download studies now

Study summaries SeQuent® Please / NEO

Randomized controlled trials

Not randomized controlled trials & observational studies

Sirolimus coated balloon

SeQuent® SCB – The pioneer of proof

B. Braun´s sirolimus coated balloon is the first SCB backed up with published randomized clinical trials for ISR and de-novo lesions.[2], [3], [4] SeQuent® SCB offers new implant-free options for treating coronary ISR and de-novo lesions, providing excellent results in targeted drug delivery and sirolimus persistence. The combination of sirolimus and BHT (Butylated Hydroxy Toluol) creates the desired crystalline sirolimus modification to reach best results regarding sirolimus vessel wall content compared to other excipients.[5]

  • SeQuent® SCB is the first coronary sirolimus coated balloon clinically proven in 5 published RCTs for coronary ISR and de novo CAD
  • Multicenter data from Europe and Asia
  • Ongoing studies for de-novo and world
SeQuent® SCB – Sirolimus coated balloon

Clinical evidence SeQuent® SCB

Preclinical work and randomized controlled trials

Related documents

References

  1. All numbers referring to clinical coronary trials on PCBs, patients enrolled therein and countries in which these trials were conducted, are based on a PubMed literature search conducted with due diligence in February/March 2022. (Data on file at B. Braun)
  2. Ali RM et al J Am Coll Cardiol Intv 2019;12:558-66
  3. Scheller B et al. Circ Cardiovasc Interv. 2022 Sep;15(9):e012305.
  4. Ahmad WAW et al. JACC Cardiovasc Interv. 2022 Apr 11;15(7):770-779
  5. Clever et al. Circ Cardiovasc Interv. 2016 Apr;9(4):e003543.